High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy (Q46725700)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy |
scientific article published in March 2008 |
Statements
1 reference
High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy (English)
1 reference
Daniel Catovsky
1 reference
Estella Matutes
1 reference
Moez Dungarwalla
1 reference
Steve O Evans
1 reference
Unell Riley
1 reference
Clare E Dearden
1 reference
1 March 2008
1 reference
1 reference
93
1 reference
3
1 reference
475-476
1 reference
Identifiers
1 reference